No abstract available
Keywords:
Apalutamid; Prostatakarzinom; Resistenz; TITAN; mHSPC.
MeSH terms
-
Androgen Antagonists / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Docetaxel / adverse effects
-
Docetaxel / therapeutic use
-
Humans
-
Male
-
Neoplasm Metastasis
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / pathology
-
Thiohydantoins / therapeutic use*
Substances
-
Androgen Antagonists
-
Thiohydantoins
-
apalutamide
-
Docetaxel